Hayden Michael R — SEC insider filings

SEC reporting owner CIK 1352908. 42 insider filings on record with FilingPulse; latest filed 2026-11-13.

Transaction summary — filings shown

Covers all 42 filings on record, filed 2020-10-19 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
AbCellera Biologics Inc. (ABCL)Director135 legs · 223,665 sh · $2,799,9761 leg · 100,000 sh · $2,550,00015
IONIS PHARMACEUTICALS INC (IONS)Director176 legs · 45,000 sh · $1,865,879—32
89bio, Inc. (ETNB)Director84 legs · 87,788 sh · $1,077,914—24
Xenon Pharmaceuticals Inc. (XENE)Director3——9
Aurinia Pharmaceuticals Inc. (AUPH)Director1——6

Insider filings — Hayden Michael R

FiledFormIssuerReported transactionsSource
2026-11-134IONIS PHARMACEUTICALS INC (IONS)Purchase (P): 5,000 @ $29.64EDGAR
2026-08-244AbCellera Biologics Inc. (ABCL)Purchase (P): 53,613 @ $10.64EDGAR
2026-08-144AbCellera Biologics Inc. (ABCL)Purchase (P): 46,387 @ $10.37EDGAR
2026-08-134AbCellera Biologics Inc. (ABCL)Gift (G): 50,000 @ $0EDGAR
2026-07-314IONIS PHARMACEUTICALS INC (IONS)Purchase (P): 15,000 @ $53.38 · Purchase (P): 5,000 @ $51.60EDGAR
2026-07-064IONIS PHARMACEUTICALS INC (IONS)Grant/award (A): 5,369 (derivative) @ $0 · Grant/award (A): 2,301 (derivative) @ $0EDGAR
2026-06-124AbCellera Biologics Inc. (ABCL)Grant/award (A): 111,701 (derivative) @ $0EDGAR
2025-10-30489bio, Inc. (ETNB)Code (U): 80,904 · Code (U): 103,978 · Code (U): 61,538 · Disposition to issuer (D): 27,647 (derivative) @ $0 · Disposition to issuer (D): 2,933 (derivative) @ $0 · Disposition to issuer (D): 22,730 (derivative) @ $0 · +7 moreEDGAR
2025-07-174IONIS PHARMACEUTICALS INC (IONS)Option exercise (M): 4,079 @ $0 · Option exercise (M): 4,079 (derivative) @ $0EDGAR
2025-07-024IONIS PHARMACEUTICALS INC (IONS)Grant/award (A): 11,518 (derivative) @ $0 · Grant/award (A): 5,220 (derivative) @ $0EDGAR
2025-07-014AbCellera Biologics Inc. (ABCL)Grant/award (A): 238,864 (derivative) @ $0EDGAR
2025-05-024IONIS PHARMACEUTICALS INC (IONS)Purchase (P): 15,000 @ $31.86EDGAR
2025-02-05489bio, Inc. (ETNB)Grant/award (A): 56,400 (derivative) @ $0EDGAR
2024-12-264IONIS PHARMACEUTICALS INC (IONS)Purchase (P): 2,500 @ $36.20 · Purchase (P): 2,500 @ $36.23EDGAR
2024-07-034IONIS PHARMACEUTICALS INC (IONS)Grant/award (A): 10,111 (derivative) @ $0 · Grant/award (A): 4,079 (derivative) @ $0EDGAR
2024-06-244AbCellera Biologics Inc. (ABCL)Grant/award (A): 163,934 (derivative) @ $0EDGAR
2024-02-05489bio, Inc. (ETNB)Grant/award (A): 45,150 (derivative) @ $0EDGAR
2023-09-264AbCellera Biologics Inc. (ABCL)Purchase (P): 20,000 @ $4.91EDGAR
2023-08-094AbCellera Biologics Inc. (ABCL)Purchase (P): 30,000 @ $5.90EDGAR
2023-07-194IONIS PHARMACEUTICALS INC (IONS)Option exercise (M): 1,777 @ $0 · Option exercise (M): 5,333 @ $0 · Option exercise (M): 1,777 (derivative) @ $0 · Option exercise (M): 5,333 (derivative) @ $0EDGAR
2023-07-064IONIS PHARMACEUTICALS INC (IONS)Grant/award (A): 10,321 (derivative) @ $0 · Grant/award (A): 4,677 (derivative) @ $0EDGAR
2023-03-30489bio, Inc. (ETNB)Purchase (P): 6,250 @ $3.62 · Purchase (P): 10,000 @ $3.48 · Purchase (P): 10,000 @ $2.67 · Purchase (P): 61,538 @ $16.15EDGAR
2023-02-13489bio, Inc. (ETNB)Grant/award (A): 27,400 (derivative) @ $0EDGAR
2022-12-054AbCellera Biologics Inc. (ABCL)Grant/award (A): 47,231 (derivative) @ $0EDGAR
2022-10-184IONIS PHARMACEUTICALS INC (IONS)Option exercise (M): 1,777 @ $0 · Option exercise (M): 1,777 (derivative) @ $0EDGAR
2022-07-194IONIS PHARMACEUTICALS INC (IONS)Option exercise (M): 5,333 @ $0 · Option exercise (M): 1,777 @ $0 · Option exercise (M): 5,333 (derivative) @ $0 · Option exercise (M): 1,777 (derivative) @ $0EDGAR
2022-07-064IONIS PHARMACEUTICALS INC (IONS)Grant/award (A): 12,000 (derivative) @ $0 · Grant/award (A): 5,333 (derivative) @ $0EDGAR
2022-05-18489bio, Inc. (ETNB)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2021-12-104AbCellera Biologics Inc. (ABCL)Grant/award (A): 34,282 (derivative) @ $0 · Grant/award (A): 45,532 (derivative) @ $0EDGAR
2021-10-194IONIS PHARMACEUTICALS INC (IONS)Option exercise (M): 1,777 @ $0 · Option exercise (M): 1,777 (derivative) @ $0EDGAR
2021-09-154AbCellera Biologics Inc. (ABCL)Option exercise (M): 270,000 @ $17.73 · Option exercise (M): 270,000 (derivative) @ $0EDGAR
2021-07-194IONIS PHARMACEUTICALS INC (IONS)Option exercise (M): 5,333 @ $0 · Option exercise (M): 1,778 @ $0 · Option exercise (M): 5,333 (derivative) @ $0 · Option exercise (M): 1,778 (derivative) @ $0EDGAR
2021-07-064IONIS PHARMACEUTICALS INC (IONS)Grant/award (A): 12,000 (derivative) @ $0 · Grant/award (A): 5,333 (derivative) @ $0EDGAR
2021-06-224AbCellera Biologics Inc. (ABCL)Sale (S): 100,000 @ $25.50EDGAR
2021-06-034Xenon Pharmaceuticals Inc. (XENE)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-05-204Xenon Pharmaceuticals Inc. (XENE)Option exercise (M): 3,500 @ $3.85 · Option exercise (M): 3,500 (derivative) @ $0EDGAR
2021-04-19489bio, Inc. (ETNB)Grant/award (A): 12,500 (derivative) @ $0EDGAR
2021-02-25489bio, Inc. (ETNB)Option exercise (M): 60,820 @ $1.93 · Option exercise (M): 6,447 @ $1.93 · Option exercise (M): 13,637 @ $3.11 · Option exercise (M): 60,820 (derivative) @ $0 · Option exercise (M): 6,447 (derivative) @ $0 · Option exercise (M): 13,637 (derivative) @ $0EDGAR
2021-02-184Xenon Pharmaceuticals Inc. (XENE)Option exercise (M): 5,144 @ $2.68 · Option exercise (M): 10,288 @ $3.67 · Option exercise (M): 30,864 @ $2.68 · Option exercise (M): 5,144 (derivative) @ $0 · Option exercise (M): 10,288 (derivative) @ $0 · Option exercise (M): 30,864 (derivative) @ $0EDGAR
2021-02-024Aurinia Pharmaceuticals Inc. (AUPH)Option exercise (M): 50,000 @ $5.44 · Option exercise (M): 30,000 @ $6.06 · Option exercise (M): 15,000 @ $6.42 · Option exercise (M): 50,000 (derivative) @ $0 · Option exercise (M): 30,000 (derivative) @ $0 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2020-12-174AbCellera Biologics Inc. (ABCL)Option exercise (M): 270,000 @ $0.33 · Conversion (C): 117,647 · Purchase (P): 73,665 @ $20 · Option exercise (M): 270,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0 · Grant/award (A) @ $2,000,000 · +1 moreEDGAR
2020-10-194IONIS PHARMACEUTICALS INC (IONS)Option exercise (M): 1,778 @ $0 · Option exercise (M): 1,778 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-19 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1352908 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs